Market Overview:
The global recombinant albumin market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for recombinant albumin in cell culture media, medical supplements, and other applications. North America is expected to dominate the global recombinant albumin market during the forecast period owing to the presence of major players and early adoption of novel technologies in this region.
Product Definition:
A recombinant protein is a protein created through genetic engineering. Recombinant albumin is an artificially made version of the blood protein albumin. It is used to treat various medical conditions, including low blood pressure, burns, and serious infections.
OsrHSA:
OsrHSA is a human serum albumin that has been modified by the addition of an amino group from porcine circulatory fluid protein. It is currently under clinical investigation in Europe and Japan for its potential use as a therapeutic protein in humans. The product was granted orphan drug status by the U.
ScrHSA:
ScrHSA is short for Scrambled Human Milk Atelectric Point. It is a protein that occurs naturally in human milk and can be produced recombinantly using genetic engineering techniques. The point at which the voltage of an electric current changes when it reaches the infant's stomach has been used as a measure of enteric competence since the early days of investigational pediatric research (1947).
Application Insights:
Cell culture media application segment led the global recombinant albumin market in 2017 and is projected to continue its dominance over the forecast period. This can be attributed to factors such as rising number of R&D activities for culturing cells, high demand from biopharmaceutical companies for protein purification and production, increasing government funding for research related to cell cultivation, and availability of a wide range of products suitable for cell cultivation.
Medical supplements are expected to witness significant growth over the forecast period owing to growing awareness regarding various health benefits associated with it. These include prevention & treatment of several diseases such as osteoporosis, liver disorders including primary biliary cirrhosis (PBC), kidney disorders including nephrotic syndrome and diabetic nephropathy among others. Increasing geriatric population prone towards osteoarthritis is also anticipated fuel product demand in medical supplements application segment during the forecast years.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The presence of a large number of companies coupled with high awareness levels and favorable government initiatives is expected to drive the regional market over the forecast period. For instance, in February 2018, Thermo Fisher Scientific Inc., a leading biotechnology company, announced funding worth USD X million from National Institute of Health (NIH) to develop novel therapies for Type 1 Diabetes (T1D). This initiative was taken to accelerate research on humanized micelles that are expected to improve treatment options for patients suffering from T1D within five years.
Asia Pacific is anticipated to be one of the fastest-growing regions due its increasing focus towards drug development programs by major players as well as public & private partnerships between universities & institutes and industry players aimed at accelerating R&D activities pertaining recombinant proteins production.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. Recombinant albumin is used as a treatment for various chronic diseases, such as renal failure, liver cirrhosis, and burns. Thus, the demand for recombinant albumin is expected to increase in the coming years.
- Growing awareness about therapeutic benefits of recombinant albumin: There has been a growing awareness among healthcare professionals and patients about the therapeutic benefits of recombinant albumin over traditional blood-based therapies. This has led to an increase in demand for recombinant albumin products worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Recombinant Albumin Market Research Report
By Type
OsrHSA, ScrHSA
By Application
Cell Culture Media, Medical Supplements, Other
By Companies
Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Recombinant Albumin Market Report Segments:
The global Recombinant Albumin market is segmented on the basis of:
Types
OsrHSA, ScrHSA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cell Culture Media, Medical Supplements, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Albumedix
- Merck
- Ventria (InVitria)
- NCPC
- Oryzogen
- HiMedia
Highlights of The Recombinant Albumin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- OsrHSA
- ScrHSA
- By Application:
- Cell Culture Media
- Medical Supplements
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Recombinant Albumin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Recombinant albumin is a protein that has been created by recombining two or more proteins. This process can be done in the laboratory, and it allows scientists to create new proteins that have never before been seen. Recombinant albumin can be used in medical treatments, and it has also been used in research studies.
Some of the major players in the recombinant albumin market are Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia.
The recombinant albumin market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Recombinant Albumin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Recombinant Albumin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Recombinant Albumin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Recombinant Albumin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Recombinant Albumin Market Size & Forecast, 2020-2028
4.5.1 Recombinant Albumin Market Size and Y-o-Y Growth
4.5.2 Recombinant Albumin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 OsrHSA
5.2.2 ScrHSA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cell Culture Media
6.2.2 Medical Supplements
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Recombinant Albumin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Recombinant Albumin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 OsrHSA
9.6.2 ScrHSA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cell Culture Media
9.10.2 Medical Supplements
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 OsrHSA
10.6.2 ScrHSA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cell Culture Media
10.10.2 Medical Supplements
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 OsrHSA
11.6.2 ScrHSA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cell Culture Media
11.10.2 Medical Supplements
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 OsrHSA
12.6.2 ScrHSA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cell Culture Media
12.10.2 Medical Supplements
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 OsrHSA
13.6.2 ScrHSA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cell Culture Media
13.10.2 Medical Supplements
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Recombinant Albumin Market: Competitive Dashboard
14.2 Global Recombinant Albumin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Albumedix
14.3.2 Merck
14.3.3 Ventria (InVitria)
14.3.4 NCPC
14.3.5 Oryzogen
14.3.6 HiMedia
